FTAI Aviation Announces Increase to Previously Announced Cash Tender Offer for its 9.750% Senior Notes Due 2027
June 03, 2024 14:52 ET
|
FTAI Aviation Ltd.
FTAI Aviation Announces Increase to Previously Announced Cash Tender Offer
for its 9.750% Senior Notes Due 2027
MCLA-129 von Merus zeigt in Posterpräsentation auf der ASCO®-Jahrestagung 2024 eine vielversprechende Wirksamkeit als Einzelwirkstoff bei METex14-NSCLC
June 03, 2024 14:30 ET
|
Merus N.V.
UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts, June 03, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) („Merus“, das „Unternehmen“, „wir“ oder „unser“), ein Unternehmen aus dem Bereich der...
L’anticorps MCLA-129 produit par Merus ou la promesse d’une monothérapie efficace dans le traitement du CPNPC présentant une mutation de l’exon 14 du gène MET - une présentation sous forme de poster est prévue lors du congrès annuel 2024 de l’ASCO®
June 03, 2024 14:30 ET
|
Merus N.V.
UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 03 juin 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), ci-après « Merus, la Société, nous, ou notre », une société spécialisée dans...
Merus’ MCLA-129 Demonstrates Promising Single-Agent Efficiency in METex14 NSCLC in Poster Presentation at the 2024 ASCO® Annual Meeting
June 03, 2024 14:30 ET
|
Merus N.V.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative,...
Inotiv Reaches Agreement to Resolve Previously-Announced Investigation into Shuttered Cumberland Facility
June 03, 2024 13:24 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., June 03, 2024 (GLOBE NEWSWIRE) -- Inotiv Inc. – Inotiv Inc. (“Inotiv” or the “Company”) (Nasdaq: NOTV), a leading contract research organization dedicated to providing...
Definitive Healthcare Publishes 2023 Sustainability Report
June 03, 2024 13:08 ET
|
Definitive Healthcare Corp.
Definitive Healthcare publishes 2023 Sustainability Report showcasing continued successes related to culture, governance, and the environment
WISe.ART Partners with Sustainable Fashion Innovation Society on Upcoming Phygital Sustainability Expo
June 03, 2024 13:03 ET
|
Wisekey International Holding Ltd.
Announcement on the Nasdaq Tower in New York City can be viewed at https://youtu.be/28nV8L_TXaw?si=Fb1_EBN7LQcLGfFb Livestreams of the Expo’s conferences...
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
June 03, 2024 12:11 ET
|
Microbot Medical Inc.
HINGHAM, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 1,566,669 shares of...
Crinetics Announces Positive Initial Findings at ENDO 2024 for Atumelnant in Two Ongoing, Open-Label Studies for the Treatment of Congenital Adrenal Hyperplasia (CAH) and ACTH-Dependent Cushing’s Syndrome (ADCS)
June 03, 2024 12:00 ET
|
Crinetics Pharmaceuticals, Inc.
100% of Participants (n=6) With CAH Maintained Androstenedione (A4) Below the Upper Limit of Normal at all Time Points on Atumelnant (80 mg) CAH Participants Achieved More Than a 90% Reduction of...
Crinetics Presents New Data at ENDO 2024 that Increases Body of Evidence Positioning Once-Daily, Oral Paltusotine as Potential First-Choice Treatment Option for Acromegaly
June 03, 2024 12:00 ET
|
Crinetics Pharmaceuticals, Inc.
First Scientific Presentation of PATHFNDR-2 Acromegaly Safety and Efficacy Data Following Positive Topline Announcement, Showing Rapid and Sustained IGF-1 Responses in People Treated with Paltusotine ...